Shared on 17 Dec 25

BIOX: Portfolio Recapitalization Progress Will Eventually Overcome Argentina Liquidity Headwinds

Analysts have trimmed their price target on Bioceres Crop Solutions by roughly $0.10 per share, citing heightened Argentina-related liquidity volatility and increased uncertainty around the company’s portfolio recapitalization efforts. Analyst Commentary Analysts acknowledge that Bioceres retains a differentiated portfolio and strategic exposure to key agricultural markets, but sentiment has turned more cautious as near term risks have become more prominent in their valuation work.

26 views

Shared on 03 Dec 25

Fair value Decreased 38%

BIOX: Next Generation Product Pipeline Will Offset Argentina Liquidity Pressures

Analysts have trimmed their price target on Bioceres Crop Solutions to around $2.25 from approximately $3.63, reflecting concerns over Argentina related liquidity pressures and portfolio recapitalization challenges, even as they continue to see long term value in the company’s next generation product pipeline. Analyst Commentary Street research on Bioceres Crop Solutions reflects a mixed backdrop, with liquidity concerns and execution risks in Argentina offset by continued confidence in the long term earnings power of its next generation product portfolio.

17 views

Shared on 19 Nov 25

Fair value Decreased 3.33%

BIOX: Portfolio Recapitalization Will Overcome Argentina Liquidity Pressure Ahead

The analyst price target for Bioceres Crop Solutions was revised downward from $3.75 to $3.63. Analysts cited increased pressure from liquidity concerns and recent portfolio challenges as key factors for the adjustment.

8 views

Shared on 02 Nov 25

Fair value Decreased 10%

Analysts have lowered their fair value price target for Bioceres Crop Solutions from $4.17 to $3.75 per share. They cite concerns about Argentina's economic volatility, recent earnings shortfalls, and increased hurdles to the company's portfolio strategy.

15 views

Shared on 18 Oct 25

Analysts have revised their price target for Bioceres Crop Solutions downward from $8 to $5, citing weaker-than-expected Q4 results and leadership transitions. However, they continue to highlight potential in the company’s pipeline for future value creation.

2 views

Shared on 04 Oct 25

Fair value Decreased 39%

Analysts have lowered their price target for Bioceres Crop Solutions from $8 to $5, citing weaker-than-expected Q4 results and concerns over executive turnover. However, they continue to see long-term value in the company's innovation pipeline.

0 views

Shared on 01 May 25

Fair value Decreased 4.03%

0 views

Shared on 23 Apr 25

Fair value Decreased 3.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

2 views

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

0 views

Shared on 09 Apr 25

Fair value Decreased 0.20%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 02 Apr 25

Fair value Decreased 5.93%

3 views

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

2 views

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 11 Mar 25

Fair value Increased 2.82%

AnalystConsensusTarget has increased revenue growth from 10.0% to 11.3%, decreased profit margin from 9.7% to 8.2%, decreased future PE multiple from 26.3x to 23.1x and increased discount rate from 25.4% to 29.9%.

1 view

BIOX: Recovery From Argentina Volatility Will Drive Future Upside Potential

BIOX: Portfolio Recapitalization Progress Will Eventually Overcome Argentina Liquidity Headwinds

BIOX: Next Generation Product Pipeline Will Offset Argentina Liquidity Pressures

BIOX: Portfolio Recapitalization Will Overcome Argentina Liquidity Pressure Ahead

Shared on 02 Nov 25

Shared on 18 Oct 25

Shared on 04 Oct 25

Shared on 01 May 25

Shared on 23 Apr 25

Shared on 17 Apr 25

Shared on 09 Apr 25

Shared on 02 Apr 25

Shared on 26 Mar 25

Shared on 19 Mar 25

Shared on 11 Mar 25

Fair Value vs Share Price

Recent News & Updates

Recent updates

Stay ahead on Bioceres Crop Solutions

Company analysis

CEO & management